NAVITUS HEALTH SOLUTIONS

Lobbying for NAVITUS HEALTH SOLUTIONS · Pharmacy benefit manager and specialty pharmacy

Filing · LD-2 quarterly report Q3 termination

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 24, 2026

Expenses

$30,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Wisconsin

Representation ended

Sep 30, 2026

The registrant reported terminating its work for this client.

Official filing document

Government bodies contacted 8

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Health Issues

Pharmacy Benefit Manger Reform, Patients Before Monopolies Act, Senior Access to Life Saving Drugs, IRA drug shortage, Drug Supply Chain reform

Insurance

ERISA protection, Pharmacy Benefit Manager Reform, Patients Before Monopolies Act, Drug supply chain transparency reform.

Pharmacy

Patients before Monopolies Act, Specialty pharmacy licensing and compensation, drug supply chain transparency reform.

Labor Issues/Antitrust/Workplace

Patients before Monopolies Act, drug supply chain reform.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.